Current
Position:
Professor of Medicine (Division of Hematology, Oncology, and
Transplantation) and Molecular Pharmacology and Therapeutics, Associate
Director for Basic Science, University of Minnesota Masonic Cancer
Center
Principal
Areas of Scientific/Medical Interest: Steroid hormone action in breast
and ovarian cancers, Mechanisms of cellular stress-induced signal
transduction, cancer stem cell biology, cancer metastasis Endocrine
Society Service: (listed in
alpha order by committee)
Annual Meeting Steering
Committee (2003 - 2006)
Basic Science Task Force
(2006 - 2011) Molecular
Endocrinology
Editorial Board (2006 - 2008)
Scientific and
Educational Programs Core Committee (2006 - 2009)
Annual Meeting Steering
Committee (Basic Science Chair) (2007 - 2008)
Publications Core
Committee (2010 - 2011), (Editor-In-Chief) (2011 - 2014) Hormones
& Cancer
(Editor-In-Chief) (2013 - 2014)
Laureate Awards
Committee (2013 - 2014)
Board of Directors (Vice
President (Basic Sci)) (2014 - 2017)
Advocacy and Public
Outreach Core Committee (Council Liaison) (2014 - 2015)
Executive Committee
(Vice President Basic Science) (2014 - 2017)
Leadership Development
Task Force (Chair) (2015 - 2015)
Publications Core
Working Group (2015 - 2015)
Nominating Committee
(2018 - 2021) Endocrinology (Editor-In-Chief) (2020 - 2026)
Honors
and Awards (Selection): Women
in Endocrinology Women’s Health Research Award (2001); American Cancer
Society Research Scholar Award (2004-2008); Tickle Family Land Grant
Endowed Chair in Breast Cancer Research; Roy O Greep Award for
Outstanding Contributions to Endocrine Research (Endocrine Society
Laureate Awards 2012); Sara Evans Award (University of MN 2012) for
Outstanding Leadership in Science and Engineering; University of MN
Mentor of the Year Award (2013); Council of Graduate Students
Outstanding Faculty Award (2014); Ada Comstock Distinguished Women
Scholars Award and Public Lecture (U of MN; 2014); Emerging Research
Award (2015); 5th District Eagles (University of MN); U of MN Research
Excellence Award (2016); NIH/NCI Up for a Challenge (U4C) Award
(co-recipient with Chad Myers; 2016); Jensen
Symposium
Memorial Plenary Lecture (2018); Annette L.
Boman Cancer Research Symposium
KeyNote Lecture (2018); Sidney H. Ingbar Laureate Award for
Distinguished Service to the Field of Endocrinology (Endocrine Society
Laureate Awards 2020); American Cancer Society ResearcHers Legacy Award
(2022); University of Minnesota Wall of
Scholarship in
recognition of highly cited work (2022); Masonic Cancer Center
Excellence in Mentoring Award (2023).
List
significant leadership commitment and involvement with other
organizations, including organizations’ names and dates. Please list
any leadership training skills.
I
am a veteran trainer with nearly 25 years of teaching, mentoring, and
leadership experience. My core strengths include my energy, enthusiasm,
love of science, and extensive experience in promoting research
excellence through exceptional mentoring and team building for original
collaborative research projects that are exciting, innovative, and
inter-disciplinary. In these roles, I have striven to raise awareness
for the need to eliminate unconscious bias and promote respect,
fairness, diversity, equity, and inclusion. Selected leadership local
and national roles that demonstrate my qualifications and core
competencies for the role of President Elect include:
Extensive service on NIH Study Sections (BCE, ICER,
Founding Member of MONC); 1999-2024
Chair, Faculty Advisory Council to the Dean (UMN School of
Medicine); 2006
Chair of Basic Science, The Endocrine Society Annual
Meeting (ENDO 2008)
Program
Director/Co-Director UMN Masonic Cancer Center (Women’s Cancer, Cell
Signaling, and Cellular Mechanisms Programs); 2009-2021
Program Director; NIH/NCI Targets of Cancer Training
Program (T32); 2009-Present
Vice President of Basic Science, The Endocrine Society;
2014-2016
Chair, Task Force on Leadership Development, The Endocrine
Society; 2015
Co-Chair, UMN Medical School Dean’s Committee on the Status
of Women in Leadership; 2015-2016. (Committee Member 2016-2020)
Research Director, UMN Powell Center of Excellence in
Women’s Health; 2015-2017
NIEHS Board of Scientific Advisors (NIH, Research Triangle
Park, NC); 2015-2021
Editor-in-Chief, Hormones
and Cancer (Springer/Nature Publishers); 2011-2015;
2017-2020
Associate Director for Basic Science/Co-Director of Shared
Resources (UMN Masonic Cancer Center); 2021-present
LEADERSHIP &
PROFESSIONAL DEVELOPMENT TRAINING 01/13-14/2021
“Transforming Conflict into Collaboration” (AAMC Virtual Workshop)
Why
do you want to serve in a leadership role and what leadership qualities
do you possess to be successful? Please describe how you embody the
required core competencies.
I
deeply enjoy strategic thinking, team building, and helping others to
be successful. My leadership accomplishments have a common thread of
mentoring and career development. I believe that leadership
encompasses recognizing opportunity and building consensus that
empowers talented people to connect and reach a common goal. Proactive
leaders enable teams or organizations to do more together than can be
accomplished alone. Leadership holds the unselfish vision that the
success of others, both individually and as a collaborative group, is a
measure of the success of the organization. In this highly competitive
climate, there is an urgent need to ensure that our most talented
Society members who are in training or newly entering professional life
continue to be successful and make timely transitions as basic and
translational scientists, clinician scientists, clinicians, and future
leaders. We must also fully engage mid-career and established members
to meet their specific needs as valued and vibrant contributors. I am
driven to help promote a stimulating and rich environment that
recognizes that everyone has something valuable to contribute, is
culturally inclusive, diverse, respectful, and innovative. I believe I
can contribute to and sustain our Society’s legacy of excellence as a
President aimed at supporting and promoting member career-focused needs
as well as our many shared interests. Together, we can enrich the
environment of our Society and our field of endocrinology by nurturing
our members at all levels, thereby ensuring a vibrant and diverse
leadership pipeline for the Society and the field of Endocrinology as
we embody the hormones-to-health mission.
Please
identify 1 short term and 1 long term issue you see facing the
profession and describe your perspective on how the Society should
address these issues.
I
believe we are facing a crisis of connection. Short-term, we are still
emerging from the damages of prolonged isolation, restricted
interactions and movements, halted/stunted collaborations, and supply
chain shortages experienced post COVID pandemic. Our young people in
training that required in-person/hands-on learning experiences were
delayed, their activities in laboratories or clinics performed in
isolation, truncated and/or reduced to simulation. All members have
endured what will likely be one of the most challenging periods of
their professional careers. We must find creative ways to reconnect.
Recently, a young Faculty approached me at a small conference and said,
“Dr. Lange, you probably don’t remember me, but ~12 years ago you had
lunch with me at ENDO, and you told me about your career path. You
inspired me to feel like I could really do this job, and here I am
today after two fellowships leading my own lab. You have no idea of the
impact you made on my career and my life!” I believe our long-term
solution is also about connections. We can do more together. The most
productive collaborations initiate organically. Our Society provides
the perfect venue for connections that are life changing. Nurturing
both spontaneous connections at ENDO and continuing to foster new
strategic structured ways of bringing people together year-round should
be our focus as we fully embrace limitless future opportunities.
Leveraging this momentum through old and new connections found within
and between our diverse interest groups will ensure a vibrant future
that is filled with discovery.
Current
Position: Associate
Professor. Head Laboratory of Metabolism and Reproduction at
Internal Medicine, Erasmus MC.
Principal
Areas of Scientific/Medical Interest: Obesity and Reproduction
(sex differences in obesity, genetic obesity, PCOS, AMH)
Endocrine
Society Service:(listed
in alpha order by committee)
Annual
Meeting Steering Committee (2011 - 2014) Endocrinology
(2013 - 2019)
Scientific and Educational Programs Core Committee (Basic Science
Chair) (2015 - 2016)
Annual Meeting Steering Committee (Basic Science Chair) (2015 - 2016) Journal of the Endocrine
Society (2016 - 2017)
Board of Directors (At Large) (2017 - 2019)
Research Affairs Core Committee (Board Representative) (2017 - 2019)
Strategic Plan Retreat (2017 - 2017)
EIC Search Committee for Endocrine
Reviews (2017 - 2017)
EIC Search Committee for Journal
of Clinical Endocrinology and Metabolism (2018 - 2019)
Communities of Practice Working Group (Chair) (2018 - 2020)
Nominating Committee (2019 - 2022), (Chair) (2020 - 2022)
Board of Directors (Ex Officio, NC Chair) (2020 - 2022)
COI Advisory Group (Ex Officio) (2021 - 2022)
Annual Meeting Steering Committee (Annual Meeting Chair) (2022 - 2023)
Early Career/DEI Reviewer advisor for the Endocrine Society Journals
(2023 – present)
Honors
and Awards (Selection): - Young investigators
award, Women in Endocrinology. 1997, 2003 List
significant leadership commitment and involvement with other
organizations, including organizations’ names and dates. Please list
any leadership training skills.
European Society of Endocrinology: - Co-chair and
co-founder European Women in Endocrinology (EUWIN), European Society of
Endocrinology (2022-present) - Co-chair Focus Area
Reproductive and Developmental Endocrinology, the European Society of
Endocrinology (2020-present) - Basic Science Chair,
Program Organizing Committee, ECE2015, European Congress of
Endocrinology (2014-2015)
ESHRE: - Basic science officer,
Special interest group (SIG) Reproductive Endocrinology, ESHRE,
2016-2019
National: -
member Program Organizing Committee of the Dutch Endo-Neuro-Psycho
meeting, Doorwerth, The Netherlands. Including chair of NVE
poster-price committee (2002-2004)
Erasmus
MC: - Executive
Committee, Research Council, Clinical and Experimental Medicine
initiative, Department of Internal Medicine, Rotterdam The Netherlands
(2020-present) - Steering committee
Obesity Center CGG (Centrum Gezond Gewicht), Rotterdam, The Netherlands
(2014-2018) Leadership
skills training: - Female Career
Development program, Erasmus MC, 2008 - Associate professor
leadership program, Erasmus MC, 2016 - Visible leadership
course, Erasmus MC, 2019 - Team-oriented
leadership course, Erasmus MC, 2023 - Several (short)
leadership training programs with the Endocrine Society
Why
do you want to serve in a leadership role and what leadership qualities
do you possess to be successful? Please describe how you embody the
required core competencies.
The Endocrine Society is
my main
professional organization. This initially started by attending its
annual meeting as a basic science graduate student, showing me how
clinical and basic science can meet and strengthen each other. Later in
my career I had the opportunity to become involved in the Endocrine
Society by serving at several leadership roles, latest as chair of
ENDO2023. This has given me an in-depth understanding of Endocrine
Society’s core mission, governance and strategic plan. All combined,
the Endocrine Society has been very influential on a professional level
but also on a personal level. It allowed me to develop my leadership
qualities and gain insight into governance. My vision and qualities
have subsequently been recognized by my department, since I was asked
to be a member of the Executive Committee of a new management structure
aimed to strengthen research between basic and clinical researchers and
tasked with daily management roles, and for which I developed the
governance structure and bylaws. My interest to serve as
President-Elect stems to give back to the Endocrine Society and help it
remain and further grow as a strong global Society for the whole
endocrine community. Throughout my various leadership positions, I
have learned that I can lead a team with different leadership styles,
different nationalities and cultures, be collaborative, solicit input
from others and give others opportunities to take the lead.
Furthermore, I am patient but when necessary be firm always keeping the
end goal in mind and with respect to others.
Please
identify
1 short term and 1 long term issue you see facing the profession and
describe your perspective on how the society should address these
issues.
Short term: There is continuous
discussion within the
Endocrine Society how to best serve our basic science contingency. This
remains important as funding is difficult and trainees opt for
different career paths. Being a basic scientist myself at a clinical
department, I strongly value the interaction between basic and clinical
scientists and embody the bench-to-bedside and vice-versa approach.
Rather than focusing on one contingency only, the Endocrine Society in
my opinion is best positioned to strengthen the connection between
basic and clinical researchers and physicians. This may also provide
means to add additional benefits for basic scientists (particular
trainees) beyond the annual ENDO meeting, which is equally important.
Long term: Since
the Endocrine Society aims to be an “innovative global community
focused on improving patient care, shaping effective policy, and
ensuring the future of our field” it is vital to be outward looking and
embrace/liaise with new areas (new technologies/fields). However, the
COVID pandemic and climate impact of (air)travel have made us more
cautious of traveling. This poses a risk that it will become more
difficult to attract these emerging fields to our Society (as we
already noticed during the ENDO2023 planning), and thereby keeping our
Society of interest, particularly for the next generation. Furthermore,
keeping the global aspect of the Endocrine Society in mind, we need to
think how we reach our international basic and clinical researchers and
physicians. This requires the need to continue to build relationships
with other (international) societies, even beyond endocrinology, to
develop joined programs.